OK
Cancel
close

You must be signed in to use this feature.

SIGN IN or REGISTER

Chabner Colloquia

Collaboration in Cancer Trials

Course Organizer: Bruce A. Chabner, MD

This annual meeting is held in collaboration with The Massachusetts General Hospital Cancer Center and designed to focus on topics that bring cancer biology to clinical application:

  • New targets and targeted agents
  • Strategies for profiling and selection of patients for targeted drug trials
  • Biomarkers and animal models to guide clinical development


CHABNER COLLOQUIUM AND 2017 STO ANNUAL MEETING

Abstract Book


Session 1:
New Insights into DNA Repair and Drug Response

2:24


Targeting the ATR Kinase in Cancer Therapy Lee Zou, PhD
Video Interview | Lecture: Audio/Slides

4:35

PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian CancerAlan D’Andrea, MD
Video Interview | Lecture: Audio/Slides

2:56

Assessing DNA Repair in Clinical TrialsTed Hong, MDVideo Interview | Lecture: Audio/Slides


Session 2: Targets That Defy Effective Therapy

1:48

Developing Therapies for Ras-driven Cancers Karen Cichowski, PhD
Video Interview | Lecture: Audio/Slides

3:07

Is FGFR Inhibition an Effective Target in Gastrointestinal Tumors?Lipika Goyal, MD
Video Interview | Lecture: Audio/Slides

2:15

Intergenic Fusions in Advanced HR+ Breast CancerLeif Ellisen, MD, PhD
Video Interview | Lecture: Audio/Slides


Session 3: Promising Drug-antibody Conjugates and Cell Death Pathway Inhibitors

4:05

Genomic and Functional Characterization of Patient Derived Xenograft Models of Small Cell Lung CancerAnna Farago, MD, PhD
Video Interview | Lecture: Audio/Slides

4:18

Antibody Drug Conjugates for Triple Negative Breast Cancer: Targeting Positive in the NegativeAditya Bardia, MD, MPH
Video Interview | Lecture: Audio/Slides

2:47

PARP in Breast CancerSteven J. Isakoff, MD, PhD
Video Interview | Lecture: Audio/Slides


Session 4: Junior Faculty Forum

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor
Spheroids
Russell Jenkins, MD, PhD
Lecture: Audio/Slides


Financial Toxicity of CancerRyan Nipp, MD, MPH
Lecture: Audio/Slides


Improving Therapy for EGFR-Mutant Lung CancersZosia Piotrowska, MD
Lecture: Audio/Slides






2017 Acknowledgments

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from:

Amgen
EcoR1 Capital
Lilly
Novartis
Pfizer